Funding health
| by Sharon Cannaby, Jean Drouin, Dean Westcott 29 Aug 2005 Topic: Countries, Public sector accounting |
|
|
England is embarking on a bold undertaking to introduce a casemix funding system more broadly and quickly than most other countries have so far attempted. While there will inevitably be some bumps along the way, the track record in Australia does bear out the view that a casemix funding system is indeed the best way forward. Sharon Cannaby, Jean Drouin and Dean Westcott report The world’s health systems are under pressure: patient expectations are rising; demand for new and expensive drugs and treatments is increasing; people are living longer; disease patterns are changing; and there are issues around workforce recruitment and retention. All this means that health costs are escalating and that health service managers need to find new and better ways of managing costs. For England, this means the roll-out of Payment by Results, a tariff based casemix funding system which, when fully operational, will help health service managers to match costs to activity, plan future service delivery and undertake fact based discussions with clinicians. These benefits, however, are yet to be realised; at present the skills of finance staff are still being tested by the challenge of implementing Payment by Results. ACCA and the HFMA, therefore, decided to run a study tour to the state of Victoria, Australia, where a diagnosis related group (DRG) based casemix funding system has been in operation for over 10 years. We knew that many of the daunting problems that are surfacing in England with the introduction of Payment by Results - system affordability, demand management and quality of costing and coding of information - also emerged in Victoria during the first few years following implementation. The aim of the study tour was to identify:
The Victorian experience Like the UK, Australia has divergent approaches to healthcare. The Federal Government is the major source of funding and directly manages and controls the policy around primary care. It retains an over-arching responsibility for secondary care through healthcare agreements with each of the states. The agreements are based on individuals being able to access the public hospital system free of charge on a basis of clinical need rather than ability to pay. In addition to their share of Commonwealth funding, states will supplement this with their own revenues and are responsible for the distribution of funding to hospital providers. Within those agreements, there is significant flexibility for each state to manage hospital care in different ways, and it is this ability to do things differently that has enabled the state of Victoria to introduce a hospital funding mechanism based upon tariffs. Introduced alongside a 10% budget cut, the new casemix funding system had a rocky start in Victoria. Although primarily a funding tool, casemix was initially viewed as a budget-cutting instrument and was confused with the policy of fiscal restraint. There were numerous roll-out problems in the first few years, including overperformance by hospitals, several revisions to cost weights and activity coding problems. However, with a mix of experimentation and resolve from the state government and users, these and other initial problems were successfully addressed. The Victorian hospital funding system uses a currency - known as weighted inlier equivalent separation (WIES) - by which hospitals are funded for each in-patient episode of care (both elective and non-elective) under health service agreements. This is effectively a weighted episode of care. The weightings are calculated from the number of separations (episodes) and the costs of a particular diagnosis-related group across the whole system. For example, if the standard rate is A$3,000/WIES and a hip replacement has a weight of 5.0, the provider is paid A$15,000. Adjustments are then made for low and high outliers. If length of stay is lower than the pre-defined boundary, the hospital receives less and, if length of stay is higher than the pre-defined boundary, the hospital receives more. This is the equivalent of using reference cost data in the UK to set relative value units. In the UK this is directly translated into the tariff. In Victoria, however, the tariff has a significant role in cost containment and takes into account both the number of WIES that the state requires and the overall budget available. Each hospital agrees a yearly target level of WIES with the Department of Human Services, which serves as the commissioner. If the hospital overperforms on the agreed WIES target, the rate/WIES declines based on a sliding scale until it reaches 2%, at which point no further payment is due. Equally, if the hospital underachieves against the WIES target, then a sliding scale of recall prices applies. This system of capping expenditure gives hospitals the incentive to accurately project their forward workload and to manage it accordingly, and means that the funding system in Victoria is not the potentially open-ended cost commitment for commissioners that many would argue Payment by Results in England could represent and that was viewed by the Victorians as potentially high risk. Not surprisingly, the impact of casemix funding has been felt across the Victorian health system. Perhaps one of the more striking features of the Victorian system, though, is transparency. Hospital executives, including clinical leads, now have a detailed grasp of their cost base. Each hospital captures costs at the individual patient level, which enables:
Lessons learned A consistent set of lessons learned emerged during our visit:
Implications for the UK Although the Victorian casemix funding system is a work in progress, all parties expressed the view that it was better than previous funding models and had no wish to return to a “block” payment system. There is talk of developing separate elective and non-elective tariffs, for example, and many would like to see more explicit benchmarking of efficiency and outcomes. Nonetheless, it is clear the UK can learn a great deal from the Victorian experience. In England, this suggests focusing on:
Sharon Cannaby is ACCA UK’s head of health sector policy. Jean Drouin is a consultant with McKinsey & Company. Dean Westcott is an ACCA Council member, chair of the ACCA Health Panel and director of finance at Harlow Primary Care Trust. | |


